Adam Rosenthal is the founder of Electra Therapeutics. Electra Therapeutics has raised $84M in total funding. Latest round: Series B.
Adam Rosenthal is the co-founder of Electra Therapeutics, a clinical-stage biotechnology company focused on treating rare immunological diseases and cancer. He served as CEO from the company's launch until December 2023. Electra Therapeutics was initially funded by Star Therapeutics and later secured an $84 million Series B round.
Full founder directory · Investor directory · Company funding database · Fundraising library